Cargando…

Challenges in Discovering Drugs That Target the Protein–Protein Interactions of Disordered Proteins

Protein–protein interactions (PPIs) outnumber proteins and are crucial to many fundamental processes; in consequence, PPIs are associated with several pathological conditions including neurodegeneration and modulating them by drugs constitutes a potentially major class of therapy. Classically, howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oláh, Judit, Szénási, Tibor, Lehotzky, Attila, Norris, Victor, Ovádi, Judit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835748/ https://www.ncbi.nlm.nih.gov/pubmed/35163473 http://dx.doi.org/10.3390/ijms23031550

Ejemplares similares

Microtubule-Associated Proteins with Regulatory Functions by Day and Pathological Potency at Night
por: Oláh, Judit, et al.
Publicado: (2020)

Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein
por: Oláh, Judit, et al.
Publicado: (2021)

Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology
por: Oláh, Judit, et al.
Publicado: (2022)

Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models
por: Lehotzky, Attila, et al.
Publicado: (2021)

Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency
por: Szabó, Adél, et al.
Publicado: (2017)

The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes
por: Norris, Vic, et al.
Publicado: (2023)

Further evidence for microtubule-independent dimerization of TPPP/p25
por: Oláh, J., et al.
Publicado: (2017)

HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
por: Schiedel, Matthias, et al.
Publicado: (2020)

Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell
por: Norris, Victor, et al.
Publicado: (2021)

Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders
por: Szénási, Tibor, et al.
Publicado: (2023)

Current Challenges and Opportunities in Designing Protein–Protein Interaction Targeted Drugs
por: Shin, Woong-Hee, et al.
Publicado: (2020)

An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data
por: Sugaya, Nobuyoshi, et al.
Publicado: (2007)

Discovering patterns in drug-protein interactions based on their fingerprints
por: Luo, Weimin, et al.
Publicado: (2012)

Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
por: Rumpf, Tobias, et al.
Publicado: (2015)

Discovering functional interaction patterns in protein-protein interaction networks
por: Turanalp, Mehmet E, et al.
Publicado: (2008)

Purinergic–Glycinergic Interaction in Neurodegenerative and Neuroinflammatory Disorders of the Retina
por: Harsing, Laszlo G., et al.
Publicado: (2021)

Motif mediated protein-protein interactions as drug targets
por: Corbi-Verge, Carles, et al.
Publicado: (2016)

Discover protein sequence signatures from protein-protein interaction data
por: Fang, Jianwen, et al.
Publicado: (2005)

Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy
por: Lehotzky, A., et al.
Publicado: (2008)

Giant Squamous Cell Papilloma of the Eyelid—Diagnostic and Therapeutic Challenges
por: Vass, Attila, et al.
Publicado: (2019)

Sensor potency of the moonlighting enzyme-decorated cytoskeleton: the cytoskeleton as a metabolic sensor
por: Norris, Vic, et al.
Publicado: (2013)

Drug discovery by targeting the protein–protein interactions involved in autophagy
por: Xiang, Honggang, et al.
Publicado: (2023)

Discovering protein–protein interaction stabilisers by native mass spectrometry
por: Bellamy-Carter, Jeddidiah, et al.
Publicado: (2021)

Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
por: Villoutreix, Bruno O, et al.
Publicado: (2014)

Mass Spectrometry-Based Methodologies for Targeted and Untargeted Identification of Protein Covalent Adducts (Adductomics): Current Status and Challenges
por: Nunes, João, et al.
Publicado: (2019)

Accumulation of the PX domain mutant Frank-ter Haar syndrome protein Tks4 in aggresomes
por: Ádám, Csaba, et al.
Publicado: (2015)

Discover Protein Complexes in Protein-Protein Interaction Networks Using Parametric Local Modularity
por: Kim, Jongkwang, et al.
Publicado: (2010)

Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes
por: Ambrus, Lídia, et al.
Publicado: (2015)

Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
por: Laraia, Luca, et al.
Publicado: (2015)

Targeting protein-protein interaction interfaces in COVID-19 drug discovery
por: Chang, Chung-ke, et al.
Publicado: (2021)

Protein kinases: drug targets for immunological disorders
por: Castelo-Soccio, Leslie, et al.
Publicado: (2023)

Discovering Protein Interactions and Characterizing Protein Function Using HaloTag Technology
por: Daniels, Danette L., et al.
Publicado: (2014)

Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets
por: He, Huiqin, et al.
Publicado: (2020)

Discovering pathways by orienting edges in protein interaction networks
por: Gitter, Anthony, et al.
Publicado: (2011)

Targeting Intrinsically Disordered Proteins through Dynamic Interactions
por: Chen, Jianlin, et al.
Publicado: (2020)

Discovering protein complexes in protein interaction networks via exploring the weak ties effect
por: Ma, Xiaoke, et al.
Publicado: (2012)

Targeting Protein–Protein Interactions in the HIF System
por: Wilkins, Sarah E., et al.
Publicado: (2016)

Proteins with Complex Architecture as Potential Targets for Drug Design: A Case Study of Mycobacterium tuberculosis
por: Mészáros, Bálint, et al.
Publicado: (2011)

Mouse protein coding diversity: What’s left to discover?
por: Lilue, Jingtao, et al.
Publicado: (2019)

Discovering Distinct Functional Modules of Specific Cancer Types Using Protein-Protein Interaction Networks
por: Shen, Ru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_07oom11fuq1ii3nlq1imk963po